Beam Therapeutics (BEAM) Gains from Investment Securities (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Gains from Investment Securities for 7 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 15992.59% to $4.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, down 73.42% year-over-year, with the annual reading at $11.3 million for FY2025, 17.81% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $4.3 million at Beam Therapeutics, down from $11.5 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $83.5 million in Q4 2021, with the low at -$1.8 million in Q2 2024.
  • Average Gains from Investment Securities over 5 years is $7.8 million, with a median of $532413.5 recorded in 2023.
  • The sharpest move saw Gains from Investment Securities crashed 682.03% in 2024, then surged 42671.21% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $83.5 million in 2021, then tumbled by 74.02% to $21.7 million in 2022, then decreased by 15.31% to $18.4 million in 2023, then plummeted by 99.85% to $27000.0 in 2024, then skyrocketed by 15992.59% to $4.3 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $4.3 million, $11.5 million, and $28000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.